| Bioactivity | (E,E)-RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s disease[1]. |
| Target | HDAC3 |
| Name | (E,E)-RGFP966 |
| CAS | 1396841-57-8 |
| Formula | C21H19FN4O |
| Molar Mass | 362.40 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jia H, et al. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington's Disease Mice. PLoS One. 2016 Mar 31;11(3):e0152498. |
(E,E)-RGFP966
CAS: 1396841-57-8 F: C21H19FN4O W: 362.40
(E,E)-RGFP966 is a selective and CNS permeable HDAC3 inhibitor that can be used for the research of Huntington’s diseas
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.